Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
recruitingnot_applicable

Closed-loop in Adults With Type 2 Diabetes

NCT06579404
recruitingnot_applicable

Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes

NCT06925217
completednot_applicable

Closing the Loop in People with Type 1 Diabetes

NCT05653050
completednot_applicable

Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)

NCT05392452
completednot_applicable

Closing the Loop in Adults With Type 1 Diabetes (CLEAR)

NCT04977908

Clinical Trials (5)

Showing 5 of 5 trials
NCT06579404Not Applicable

Closed-loop in Adults With Type 2 Diabetes

Recruiting
NCT06925217Not Applicable

Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes

Recruiting
NCT05653050Not Applicable

Closing the Loop in People with Type 1 Diabetes

Completed
NCT05392452Not Applicable

Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)

Completed
NCT04977908Not Applicable

Closing the Loop in Adults With Type 1 Diabetes (CLEAR)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5